Paul Bleicher

Paul Bleicher serves as an Executive Partner at Ardan Equity, focusing on middle market healthcare software and data investments. As Co-Founding Advisor at Petri, Bleicher contributes to funding formation-stage startups at the intersection of biology and engineering. Additionally, Bleicher is a member of the Board of Directors at uMed, a technology platform for clinical research, and holds the position of Principal at Evident Health Strategies, providing strategic advice to investors and companies. Previous roles include CEO of OptumLabs, Chief Medical Officer at Humedica, and Chairman and Founding CEO of Phase Forward. Paul Bleicher's academic background includes advanced medical degrees and fellowships from prestigious institutions such as Harvard Medical School and the University of Rochester School of Medicine and Dentistry.